Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARA290 for emotional processing in healthy volunteers
NCT02070783Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2012
- Primary completion
- Feb 2013
- Modality
- Recombinant Proteins and Enzymes, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of cibinetide in major depressive disorder (MDD), sponsored by Leiden University Medical Center. Started Feb 2012; status: completed.
02
Drugs
cibinetide
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02070783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02070783.